In­no­force gets $96M to build up Chi­na cam­pus, in­clud­ing a new Ther­mo Fish­er-part­nered mon­o­clon­al an­ti­body man­u­fac­tur­ing fa­cil­i­ty

Sev­er­al months af­ter com­plet­ing what it calls a “Pre-A” fi­nanc­ing round, Chi­nese con­tract man­u­fac­tur­er In­no­force Phar­ma­ceu­ti­cals is back at the ven­ture well, draw­ing $96 mil­lion to build up its Hangzhou cam­pus. This time, it’s bring a big-name part­ner along.

The mon­ey will go straight to con­struc­tion, In­no­force said, with blue­prints for a new mon­o­clon­al an­ti­body man­u­fac­tur­ing fa­cil­i­ty through a part­ner­ship with Ther­mo Fish­er Sci­en­tif­ic.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER